Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Forecasted Expansion Rate of the Endometriosis Market Over the 2025–2034 Period?

The market size of endometriosis has seen significant expansion in the recent past. The market is predicted to increase from $1.4 billion in 2024 to $1.55 billion in 2025, fuelled by a compound annual growth rate (CAGR) of 10.2%. The considerable growth during the historical period is due to factors such as later diagnosis and heightened awareness, advancements in laparoscopic surgery, hormonal treatments, along with patient advocacy and support groups.

Over the next several years, considerable expansion is anticipated for the endometriosis market. The estimated increase would bring the value up to $2.21 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. The predicted progress during this forecast period is linked to the introduction of minimally invasive procedures, advancements in pharmaceuticals, and developments in genetic and epigenetic research, along with ongoing global improvements in women’s healthcare. The forthcoming period also expects to witness significant trends such as patient-focused care, precision medicine, virtual care and telemedicine, as well as fertility preservation.

What Combination of Drivers Is Leading to Accelerated Growth in the endometriosis Market?

The rise in ovarian cancer cases is anticipated to stimulate the expansion of the endometriosis market. Originating in the ovaries – the female reproductive organs that produce eggs as well as estrogen and progesterone hormones – ovarian cancer has been linked to a greater likelihood of being diagnosed with epithelial ovarian cancer, specifically the endometrioid and clear cell cancer subtypes. These subtypes are marked by high levels of estrogen, escalating the potential threat of ovarian cancer. By January 2023, the American Cancer Society forecasts that nearly 19,710 fresh incidences of ovarian cancer will be discovered among U.S. women. Ovarian Cancer Research Alliance also reported in 2022 that ovarian cancer was responsible for 12,810 deaths, a figure that rose to 13,270 by 2023. Such a rise in ovarian cancer cases is contributing to the endometriosis market’s growth. The headline “Endometriosis Market Driver: Government Funding Boosting Endometriosis Market Growth” refers to the expected endometriosis market growth due to an increase in government funding. Such funding is financial aid provided by the government to non-government bodies, typically through grants or contracts awarded for clinical research. For example, in March 2022 the U.S. federal government invested $92 million into the National Institute of Child Health and Human Development (NICHD) and earmarked $370 million for the Department of Defense’s Peer-Reviewed Medical Research Programme (PRMRP) in support of endometriosis research. Thus, government funding is a critical driver of the endometriosis market’s growth.

Explore Comprehensive Insights Into The Global Endometriosis Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp

Who Are the Leading Organizations Fueling the Expansion of the Endometriosis Market?

Major companies operating in the endometriosis market are:

• Pfizer Inc._x000D_

• F. Hoffmann-La Roche AG_x000D_

• Merck And Co. Inc._x000D_

• Abbvie Inc._x000D_

• Bayer AG_x000D_

Which Cutting-Edge Trends Are Expected to Drive the Endometriosis Market’s Growth?

Leading entities in the endometriosis market are concentrating on the creation and regulatory approval of innovative drugs like Myfembree to expand patient treatment alternatives. The advent of these advanced medicines fulfills a long-existing market gap for effective endometriosis treatment. For example, in August 2022, both Switzerland’s Myovant Sciences GmbH and America’s Pfizer Inc. received the green light from the U.S. Food and Drug Administration (FDA) to distribute Myfembree for managing moderate to intense endometriosis-related pain in premenopausal women. As a daily pill boasting three key ingredients – relugolix, estradiol, and norethindrone acetate – Myfembree offers confirmed respite for premenopausal women, addressing two indications with a single pill. Subsequently, this serves as an alternative remedy for women preferring to avoid hormone therapy or where such therapy isn’t viable.

Secure Your Global Endometriosis Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

What Are the Core Segments of the Endometriosis Market, and How Do They Contribute to Growth?

The endometriosis market covered in this report is segmented –

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

2) By Treatment Type: Hormonal Therapy, Pain Management

3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Endometriotic Nodules, Peritoneal Endometriosis

2) By Endometrioma: Chocolate Cysts

3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis, Ureteral Endometriosis, Vaginal Endometriosis

4) By Other Types: Abdominal Endometriosis, Thoracic Endometriosis

Which Regions Are Most Influential in Expanding the Endometriosis Market?

North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Does the Definition of the Endometriosis Market Include?

Endometriosis is a chronic medical condition that occurs when tissue similar to the lining of the uterus (endometrium) grows outside the uterus. The condition can cause severe pain in the pelvis and make it harder to get pregnant. It can significantly impact a person’s quality of life and fertility.

Browse Through More Similar Reports By The Business Research Company:

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Fertility Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Fertility Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: